What's in Ophthalmic Consultants of Boston's pipeline?

Ophthalmic Consultants of Boston has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Ophthalmic Consultants of Boston's portfolio?

Top competitors by shared drug class: Bayer, Alvotech Swiss AG, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Bayer AG, Carolina Eyecare Physicians, LLC.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ophthalmic-consultants-of-boston.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Ophthalmic Consultants of Boston — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ophthalmic Consultants of Boston pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Intravitreal Aflibercept Injection	Intravitreal Aflibercept Injection	marketed	VEGF inhibitor / Soluble decoy receptor	VEGF-A, VEGF-B, PlGF (Placental Growth Factor)	Ophthalmology
Moxifloxacin ophthalmic solution 0.5%	Moxifloxacin ophthalmic solution 0.5%	marketed	Fluoroquinolone antibiotic	DNA gyrase; Topoisomerase IV	Ophthalmology / Infectious Disease

Therapeutic area mix

Ophthalmology · 1
Ophthalmology / Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bayer · 2 shared drug classes
Alvotech Swiss AG · 1 shared drug class
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · 1 shared drug class
Bayer AG · 1 shared drug class
Carolina Eyecare Physicians, LLC · 1 shared drug class
Connect Biopharma Australia Pty Ltd · 1 shared drug class
Allergan · 1 shared drug class
Ahmad Zeeshan Jamil · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ophthalmic Consultants of Boston:

Cite this brief

Drug Landscape (2026). Ophthalmic Consultants of Boston — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ophthalmic-consultants-of-boston. Accessed 2026-05-17.